• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

食管癌动态预测模型的开发与应用

Development and application of a dynamic prediction model for esophageal cancer.

作者信息

Du Kunpeng, Li Lixian, Wang Qi, Zou Jingwen, Yu Zhongjian, Li Jiqiang, Zheng Yanfang

机构信息

Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou, China.

Oncology Center, Zhujiang Hospital of Southern Medical University, Guangzhou, China.

出版信息

Ann Transl Med. 2021 Oct;9(20):1546. doi: 10.21037/atm-21-4964.

DOI:10.21037/atm-21-4964
PMID:34790752
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8576729/
Abstract

BACKGROUND

Current prediction models of esophageal cancer (EC) are limited to predicting at a specific time point, and ignore changes in hazard ratios of predictive variables, known as time-varying effects. Our study aimed to investigate variables with time-varying effects in EC and to develop a prediction model that can update the 5-year predicted dynamic overall survival (DOS) probability during the follow-up period.

METHODS

Firstly, the clinicopathological information and survival data of 4,541 patients with EC was obtained from the Surveillance, Epidemiology, and End Results (SEER) database between 2007 and 2011 for modeling. Secondly, the time-varying effect of variables was assessed and the dynamic prediction model was developed based on the proportional baselines landmark supermodel.

RESULTS

Here, we found that age at diagnosis, sex, location of primary tumor, histological type, chemotherapy, surgery, and T stage showed significant time-varying effects on overall survival. Thirdly, the prediction model was validated by an internal SEER validation cohort and a Chinese patient cohort, respectively, and achieved promising results as follows: area under the curve (AUC) =0.733 (internal validation) and 0.864 (external validation). The heuristic shrinkage factor was 0.995. Finally, several clear cases were selected as examples for model application to map the patient's 5-year DOS curves and to respectively demonstrate the impact of different variables' time-varying effect on survival.

CONCLUSIONS

Overall, our results suggest that the existence of time-varying effect highlights the importance of updating the predicted survival probability during the follow-up period. Moreover, this prediction model can be used to assist doctors in making more-individualized treatment decisions based on a dynamic assessment of patient prognosis.

摘要

背景

目前食管癌(EC)的预测模型仅限于在特定时间点进行预测,而忽略了预测变量风险比的变化,即所谓的时变效应。我们的研究旨在调查EC中具有时变效应的变量,并开发一种预测模型,该模型可以在随访期间更新5年预测动态总生存(DOS)概率。

方法

首先,从监测、流行病学和最终结果(SEER)数据库中获取2007年至2011年间4541例EC患者的临床病理信息和生存数据用于建模。其次,评估变量的时变效应,并基于比例基线地标超模型开发动态预测模型。

结果

在此,我们发现诊断时年龄、性别、原发肿瘤位置、组织学类型、化疗、手术和T分期对总生存有显著时变效应。第三,该预测模型分别通过SEER内部验证队列和中国患者队列进行验证,并取得了如下良好结果:曲线下面积(AUC)=0.733(内部验证)和0.864(外部验证)。启发式收缩因子为0.995。最后,选择几个典型病例作为模型应用示例,绘制患者的5年DOS曲线,并分别展示不同变量时变效应对生存的影响。

结论

总体而言,我们的结果表明时变效应的存在凸显了在随访期间更新预测生存概率的重要性。此外,该预测模型可用于协助医生基于对患者预后的动态评估做出更个体化的治疗决策。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/94275be9af49/atm-09-20-1546-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/eff8ebb81379/atm-09-20-1546-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/15e1d3bb56dc/atm-09-20-1546-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/c828584a7c56/atm-09-20-1546-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/a0d2f26f730f/atm-09-20-1546-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/94275be9af49/atm-09-20-1546-f5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/eff8ebb81379/atm-09-20-1546-f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/15e1d3bb56dc/atm-09-20-1546-f2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/c828584a7c56/atm-09-20-1546-f3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/a0d2f26f730f/atm-09-20-1546-f4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8680/8576729/94275be9af49/atm-09-20-1546-f5.jpg

相似文献

1
Development and application of a dynamic prediction model for esophageal cancer.食管癌动态预测模型的开发与应用
Ann Transl Med. 2021 Oct;9(20):1546. doi: 10.21037/atm-21-4964.
2
Dynamic prediction and prognostic analysis of patients with cervical cancer: a landmarking analysis approach.宫颈癌患者的动态预测和预后分析:一种定标分析方法。
Ann Epidemiol. 2020 Apr;44:45-51. doi: 10.1016/j.annepidem.2020.01.009. Epub 2020 Mar 4.
3
Development and External Validation of Survival Prediction Model for Pancreatic Cancer Using Two Nationwide Databases: Surveillance, Epidemiology and End Results (SEER) and Korea Tumor Registry System-Biliary Pancreas (KOTUS-BP).利用两个全国性数据库:监测、流行病学和最终结果(SEER)和韩国肿瘤登记系统-胆道胰腺(KOTUS-BP)开发和验证胰腺癌生存预测模型。
Gut Liver. 2021 Nov 15;15(6):912-921. doi: 10.5009/gnl20306.
4
[Prediction model for survival in patients with biliary tract cancer: a development and validation study].[胆管癌患者生存预测模型:一项开发与验证研究]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Nov 10;40(11):1461-1469. doi: 10.3760/cma.j.issn.0254-6450.2019.11.022.
5
Does the SORG Algorithm Predict 5-year Survival in Patients with Chondrosarcoma? An External Validation.SORG 算法能否预测软骨肉瘤患者的 5 年生存率?一项外部验证。
Clin Orthop Relat Res. 2019 Oct;477(10):2296-2303. doi: 10.1097/CORR.0000000000000748.
6
Nomograms-based prediction of overall and cancer-specific survivals for patients diagnosed with major salivary gland carcinoma.基于列线图对确诊为大唾液腺癌患者的总生存期和癌症特异性生存期的预测
Ann Transl Med. 2021 Aug;9(15):1230. doi: 10.21037/atm-21-1725.
7
Prediction of overall survival in patients with Stage I esophageal cancer: A novel web-based calculator.Ⅰ期食管癌患者总生存预测:一种新型网络计算器。
J Surg Oncol. 2021 Oct;124(5):767-779. doi: 10.1002/jso.26594. Epub 2021 Jul 14.
8
Can a Nomogram Help to Predict the Overall and Cancer-specific Survival of Patients With Chondrosarcoma?列线图能否预测软骨肉瘤患者的总生存和癌症特异性生存?
Clin Orthop Relat Res. 2018 May;476(5):987-996. doi: 10.1007/s11999.0000000000000152.
9
Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.预测小唾液腺癌:一种用于总生存和癌症特异性生存的新的列线图和风险分类系统。
Otolaryngol Head Neck Surg. 2021 Feb;164(2):359-368. doi: 10.1177/0194599820938323. Epub 2020 Jul 21.
10
A Web-Based Prediction Model for Cancer-Specific Survival of Elderly Patients With Early Hepatocellular Carcinoma: A Study Based on SEER Database.基于 SEER 数据库的老年早期肝细胞癌患者癌症特异性生存的网络预测模型研究。
Front Public Health. 2022 Jan 13;9:789026. doi: 10.3389/fpubh.2021.789026. eCollection 2021.

引用本文的文献

1
Assessing biomarker trajectories for mortality risk in peritoneal dialysis: A focus on multivariate joint modeling.评估腹膜透析患者死亡风险的生物标志物轨迹:聚焦多变量联合建模。
PLoS One. 2025 Jul 28;20(7):e0320385. doi: 10.1371/journal.pone.0320385. eCollection 2025.
2
Personalized prognostic model for colorectal cancer in the era of precision medicine: a dynamic approach based on real-world data.精准医学时代的结直肠癌个性化预后模型:一种基于真实世界数据的动态方法。
Int J Clin Oncol. 2025 May 1. doi: 10.1007/s10147-025-02766-6.
3
The reporting quality and methodological quality of dynamic prediction models for cancer prognosis.

本文引用的文献

1
Moving beyond the Cox proportional hazards model in survival data analysis: a cervical cancer study.超越生存数据分析中的 Cox 比例风险模型:宫颈癌研究。
BMJ Open. 2020 Jul 19;10(7):e033965. doi: 10.1136/bmjopen-2019-033965.
2
The time-varying effect of radiotherapy after breast-conserving surgery for DCIS.保乳手术后放疗的时变效应(DCIS)。
Breast Cancer Res Treat. 2019 Nov;178(1):221-230. doi: 10.1007/s10549-019-05377-8. Epub 2019 Jul 31.
3
Dynamic prediction of overall survival for patients with high-grade extremity soft tissue sarcoma.
癌症预后动态预测模型的报告质量和方法学质量。
BMC Med Res Methodol. 2025 Mar 1;25(1):58. doi: 10.1186/s12874-025-02516-2.
高级别肢体软组织肉瘤患者总生存期的动态预测
Surg Oncol. 2018 Dec;27(4):695-701. doi: 10.1016/j.suronc.2018.09.003. Epub 2018 Sep 7.
4
A Novel Nomogram and Risk Classification System Predicting the Cancer-Specific Survival of Patients with Initially Diagnosed Metastatic Esophageal Cancer: A SEER-Based Study.一种基于 SEER 的预测初诊转移性食管癌患者癌症特异性生存的新型列线图和风险分类系统。
Ann Surg Oncol. 2019 Feb;26(2):321-328. doi: 10.1245/s10434-018-6929-0. Epub 2018 Oct 24.
5
Prediction models for patients with esophageal or gastric cancer: A systematic review and meta-analysis.食管癌或胃癌患者的预测模型:系统评价与荟萃分析
PLoS One. 2018 Feb 8;13(2):e0192310. doi: 10.1371/journal.pone.0192310. eCollection 2018.
6
Thirty-Year Trends of Survival and Time-Varying Effects of Prognostic Factors in Patients With Metastatic Breast Cancer-A Single Institution Experience.三十年来转移性乳腺癌患者生存趋势及预后因素的时变效应——单中心经验。
Clin Breast Cancer. 2018 Jun;18(3):246-253. doi: 10.1016/j.clbc.2017.08.012. Epub 2017 Sep 1.
7
Epidemiology of Esophageal Squamous Cell Carcinoma.食管鳞状细胞癌的流行病学
Gastroenterology. 2018 Jan;154(2):360-373. doi: 10.1053/j.gastro.2017.08.023. Epub 2017 Aug 18.
8
The Epidemiology of Esophageal Adenocarcinoma.食管腺癌的流行病学。
Gastroenterology. 2018 Jan;154(2):390-405. doi: 10.1053/j.gastro.2017.07.046. Epub 2017 Aug 3.
9
Nomogram-based prediction of survival in patients with advanced oesophagogastric adenocarcinoma receiving first-line chemotherapy: a multicenter prospective study in the era of trastuzumab.基于列线图预测晚期食管胃腺癌患者一线化疗生存率:曲妥珠单抗时代的多中心前瞻性研究
Br J Cancer. 2017 Jun 6;116(12):1526-1535. doi: 10.1038/bjc.2017.122. Epub 2017 May 2.
10
Annual Report to the Nation on the Status of Cancer, 1975-2014, Featuring Survival.《1975 - 2014年美国癌症现状年度报告:聚焦生存率》
J Natl Cancer Inst. 2017 Sep 1;109(9). doi: 10.1093/jnci/djx030.